Edwards Lifesciences (EW) Inventory Average (2010 - 2026)

Edwards Lifesciences' Inventory Average history runs 17 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

• On a quarterly basis, Inventory Average rose 2.03% year-over-year to $1.1 billion in Q1 2026; TTM through Mar 2026 was $1.1 billion, a 2.03% increase from a year earlier, with the FY2025 full-year figure at $1.1 billion, up 11.19% from the prior year.
• Inventory Average retreated to $1.1 billion in Q1 2026 per EW's latest filing, from $1.1 billion in the prior quarter.
• Across five years, Inventory Average topped out at $1.1 billion in Q3 2025 and bottomed at $728.6 million in Q1 2022.
• The 5-year median for Inventory Average is $1.1 billion (2024), against an average of $988.4 million.
• Across the five-year window, Inventory Average retreated 7.19% in 2022 and surged 34.37% in 2023, its largest moves.
• Year by year, Inventory Average stood at $816.6 million in 2022, then rose by 18.53% to $968.0 million in 2023, then increased by 13.17% to $1.1 billion in 2024, then climbed by 3.48% to $1.1 billion in 2025, then retreated by 0.97% to $1.1 billion in 2026.
• Per Business Quant, the three latest EW Inventory Average figures stand at $1.1 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.1 billion (Q3 2025).